PrEP Drug Assistance Program (PrEPDAP)

PrEP, when taken as prescribed prior to sex and/or injection drug use can significantly reduce the risk of contracting HIV.

Three medications are currently approved by the FDA for use as PrEP:

• emtricitabine/tenofovir disoproxil fumarate (Truvada and generic)
• emtricitabine/tenofovir alafenamide fumarate (Descovy)
• cabotegravir (Apretude), injectable PrEP

To be eligible to enroll in the Massachusetts Pre-Exposure Prophylaxis Drug Assistance Program, you must:

• Live in Massachusetts
• Be HIV-negative
• Meet income eligibility guidelines of a gross annual income not exceeding 500 percent of the federal poverty level (500% FPL). For 2024, that amount is $75,300, with an allowance of $5,380 per dependent.

Immigration status does not affect eligibility.

To enroll, complete a PrEPDAP Application and send the completed and signed form with all supporting documentation through one of the methods below:

• Fax to 617.502.1701
• Email to the PrEPDAP Team through our secure portal
• Mail to:

Community Resource Initiative
ATTN: PrEP Drug Assistance Program (PrEPDAP)
The Schrafft’s City Center
529 Main Street, Suite 301
Boston, MA 02129

Please read our step by step instruction guide and client agreement.

• PrEPDAP Application
• PrEPDAP Application Instructions
• PrEPDAP Client Agreement
• PrEPDAP Grievance Procedure
• PrEPDAP Case Manager Letter Template

1. Please fill out the application clearly and completely.
2. Make a copy of your application for your records.
3. Once we receive your completed application materials, please allow at least 24-48 hours for the PrEPDAP team to process and approve your application.
4. All information submitted as part of your PrEPDAP application is kept strictly confidential
5. Once you are enrolled in PrEPDAP, you will need to recertify your information every year to stay active in the program.